ServicenavigationHauptnavigationTrailKarteikarten

Forschungsstelle
INNOSUISSE
Projektnummer
62192.1 IP-LS
Projekttitel
Glycopeptides to drive an anti-tumour immune response and improve outcomes in cancer immunotherapies (Innolink: 101.651 IP-LS)
Projekttitel Englisch
Glycopeptides to drive an anti-tumour immune response and improve outcomes in cancer immunotherapies (Innolink: 101.651 IP-LS)

Texte zu diesem Projekt
 DeutschFranzösischItalienischEnglisch
Kurzbeschreibung
Anzeigen
-
-
Anzeigen
Abstract
Anzeigen
-
-
-

Erfasste Texte


KategorieText
Kurzbeschreibung
(Deutsch)
Glycopeptides to drive an anti-tumour immune response and improve outcomes in cancer immunotherapies (Innolink: 101.651 IP-LS)
Kurzbeschreibung
(Englisch)
Glycopeptides to drive an anti-tumour immune response and improve outcomes in cancer immunotherapies
Abstract
(Deutsch)
Most cancer patients do not respond to immunotherapies. Altered glycosylation of tumors is a signature of cancer development, making glycans an emerging target. The project studies glycopeptides as novel therapeutics that steer immune responses to control tumor growth and enhance treatment response.